Galectin Therapeutics Inc. (FRA:PHPN)
Germany · Delayed Price · Currency is EUR 4.780
0.00 (0.00%)
Last updated: Dec 1, 2025, 8:05 AM CET
Galectin Therapeutics Market Cap
Galectin Therapeutics has a market cap or net worth of €305.58 million as of December 1, 2025. Its market cap has increased by 75.88% in one year.
Market Cap
305.58M
Enterprise Value
406.00M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.78
Market Cap Chart
Since September 4, 2002, Galectin Therapeutics's market cap has increased from 31.76M to 305.58M, an increase of 862.30%. That is a compound annual growth rate of 10.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 318.60M | 307.40% |
| Dec 31, 2024 | 78.20M | -15.81% |
| Dec 29, 2023 | 92.88M | 47.83% |
| Dec 30, 2022 | 62.83M | -41.83% |
| Dec 31, 2021 | 108.01M | 3.34% |
| Dec 31, 2020 | 104.52M | -27.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |